Latest SPRO reports update at 2024-05-15: 2024-Q12023-Q42023-Q1
Spero Therapeutics logo
Spero Therapeutics SPRO
$ 1.36 -0.73%

Spero Therapeutics Operating Expenses 2011-2024 | SPRO

Annual Operating Expenses Spero Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
82.3 M 95.7 M 106 M 88.4 M 81.4 M 46.8 M 43.7 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
106 M 43.7 M 77.8 M

Quarterly Operating Expenses Spero Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
23.2 M - 27.4 M 15.6 M 16.3 M - 13.8 M 28.1 M 32.3 M - 25.6 M 23.7 M 26.7 M - 23 M 20.2 M 24.5 M 29.5 M 22.6 M 15.8 M 13.4 M 12.8 M 11.6 M 10.4 M 12 M 15 M 10.6 M 10.4 M 7.74 M 9.14 M 7.91 M 8.08 M 8.42 M - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
32.3 M 7.74 M 17.4 M